Ash Jayagopal

Company: Opus Genetics

Job title: Chief Scientific & Development Officer

Seminars:

Developing AAV Gene Therapies for BEST1-Associated Inherited Retinal Disease That Ensures IND Success 4:30 pm

Engineering of a safe, efficacious RPE selective AAV vector for delivery of BEST1 in dominant and recessive forms of the disease Proof of concept in cellular and large animal models of BEST1 Development of clinical endpoints for a P1/2 BEST1 clinical trial Read more

day: Conference Day One